Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Pituitary Neoplasms × lanreotide × Clear all

Phase

Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroendocrine Tumors 2 Acromegaly 2 Pituitary Neoplasms 1 Neuroendocrine Tumour With Carcinoid Symptoms 1 Neoplasms 1 Gigantism 1 Gastro-enteropancreatic neuroendocrine tumor 1

Interventions

Dexmedetomidine 3 Cabergoline 3 pegvisomant 1 pasireotide 1 lanreotide 1 Trimethoprim 1 Sulfamethoxazole 1 Sodium Chloride 1 Sevoflurane 1 Saline Solution 1 Propofol 1 Octreotide 1 Ibuprofen 1 Hormone Replacement Therapy 1 Cefdinir 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01861717 2021-09-30

A Pilot Study of Pre- and Post-operative Use of Somatuline Depot.

Saint John's Cancer Institute

Phase 4 Terminated

4 enrolled 5 charts

Acromegaly, Gigantism, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡